KemPharm Current Ratio 2014-2020 | KMPH

KemPharm current ratio from 2014 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
KemPharm Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $0.01B $0.08B 0.07
2019-12-31 $0.01B $0.01B 1.22
2019-09-30 $0.01B $0.01B 0.83
2019-06-30 $0.01B $0.02B 0.58
2019-03-31 $0.02B $0.02B 1.01
2018-12-31 $0.02B $0.01B 1.98
2018-09-30 $0.02B $0.02B 0.91
2018-06-30 $0.03B $0.02B 1.76
2018-03-31 $0.04B $0.01B 2.83
2017-12-31 $0.05B $0.01B 3.99
2017-09-30 $0.05B $0.01B 7.55
2017-06-30 $0.06B $0.01B 8.40
2017-03-31 $0.06B $0.01B 13.11
2016-12-31 $0.07B $0.01B 11.20
2016-09-30 $0.07B $0.01B 11.44
2016-06-30 $0.09B $0.01B 11.44
2016-03-31 $0.11B $0.01B 19.06
2015-12-31 $0.05B $0.01B 6.48
2015-09-30 $0.06B $0.01B 8.78
2015-06-30 $0.07B $0.01B 13.20
2015-03-31 $0.01B $0.00B 2.56
2014-12-31 $0.01B $0.00B 2.61
2014-09-30 $0.00B 0.00
2014-06-30 $0.00B 0.00
2014-03-31 $0.00B 0.00
2013-12-31 $0.00B $0.01B 0.39
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.012B $0.013B
KemPharm Inc. is a specialty pharmaceutical company which is engaged in the discovery and development of new molecular entity prodrugs. Its product candidates include KP201/APAP, KP511/ER and KP606/ER for the treatment of pain; KP415 for the treatment of attention deficit hyperactivity disorder and KP303 for the treatment of central nervous system disorders, which are in preclinical trail stage. The Company through its LAT platform technology generate prodrug. KemPharm Inc. is based in CORALVILLE, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $64.421B 36.56
Takeda Pharmaceutical (TAK) Japan $60.753B 10.65
Astellas Pharma (ALPMY) Japan $31.864B 15.92
Eisai (ESALY) Japan $21.826B 40.66
UCB SA (UCBJF) Belgium $17.894B 0.00
Merck (MKGAF) Germany $13.952B 18.30
Grifols, S.A (GRFS) Spain $13.283B 16.51
Catalent (CTLT) United States $11.383B 44.01
Neurocrine Biosciences (NBIX) United States $11.061B 51.12
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Ionis Pharmaceuticals (IONS) United States $7.819B 41.57
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.391B 0.00
Orion OYJ (ORINY) Finland $6.879B 30.82
IPSEN SA ADR (IPSEY) France $6.342B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.273B 10.04
United Therapeutics (UTHR) United States $5.141B 9.74
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Nektar Therapeutics (NKTR) United States $4.067B 0.00
ChemoCentryx (CCXI) United States $3.905B 0.00
Evotec AG (EVTCY) Germany $3.888B 62.70
Hypermarcas (HYPMY) Brazil $3.658B 11.13
Arrowhead Pharmaceuticals (ARWR) United States $3.427B 374.11
FibroGen (FGEN) United States $3.294B 0.00
PTC Therapeutics (PTCT) United States $3.121B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.613B 10.74
Sage Therapeutics (SAGE) United States $1.956B 0.00
Pacira BioSciences (PCRX) United States $1.881B 38.49
Xencor (XNCR) United States $1.834B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.789B 0.00
USANA Health Sciences (USNA) United States $1.778B 18.23
Corcept Therapeutics (CORT) United States $1.736B 17.22
Heron Therapeutics (HRTX) United States $1.722B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.697B 12.99
Zogenix (ZGNX) United States $1.648B 0.00
Akebia Therapeutics (AKBA) United States $1.602B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.584B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.482B 15.97
Portola Pharmaceuticals (PTLA) United States $1.404B 0.00
Karyopharm Therapeutics (KPTI) United States $1.375B 0.00
Indivior (INVVY) United States $1.362B 16.91
Tilray (TLRY) Canada $1.328B 0.00
Translate Bio (TBIO) United States $1.235B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.224B 0.00
Esperion Therapeutics (ESPR) United States $1.098B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.014B 45.28
Endo (ENDP) Ireland $0.903B 1.40
ImmunoGen (IMGN) United States $0.848B 0.00
Collegium Pharmaceutical (COLL) United States $0.798B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.777B 0.00
Molecular Templates (MTEM) United States $0.726B 0.00
Aerie Pharmaceuticals (AERI) United States $0.669B 0.00
Ardelyx (ARDX) United States $0.668B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.573B 0.00
Radius Health (RDUS) United States $0.564B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.557B 0.00
Innate Pharma SA (IPHYF) France $0.555B 0.00
Harpoon Therapeutics (HARP) United States $0.542B 0.00
DURECT (DRRX) United States $0.510B 0.00
Trillium Therapeutics (TRIL) Canada $0.506B 0.00
Siga Technologies (SIGA) United States $0.498B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.458B 11.07
BioSpecifics Technologies Corp (BSTC) United States $0.449B 17.54
Calithera Biosciences (CALA) United States $0.416B 0.00
Flexion Therapeutics (FLXN) United States $0.398B 0.00
Ocular Therapeutix (OCUL) United States $0.369B 0.00
Organogenesis Holdings (ORGO) United States $0.367B 0.00
MEI Pharma (MEIP) United States $0.356B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.351B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.344B 0.00
TherapeuticsMD (TXMD) United States $0.323B 0.00
Lannett Co Inc (LCI) United States $0.309B 6.78
Avadel Pharmaceuticals (AVDL) Ireland $0.302B 0.00
Concert Pharmaceuticals (CNCE) United States $0.298B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.288B 0.00
CASI Pharmaceuticals (CASI) United States $0.280B 0.00
Rafael Holdings (RFL) United States $0.274B 0.00
Redhill Biopharma (RDHL) Israel $0.247B 0.00
OptiNose (OPTN) United States $0.208B 0.00
KalVista Pharmaceuticals (KALV) United States $0.203B 0.00
Xeris Pharmaceuticals (XERS) United States $0.203B 0.00
PROFOUND MEDICL (PROF) Canada $0.201B 0.00
VAXART, INC (VXRT) United States $0.195B 0.00
Jounce Therapeutics (JNCE) United States $0.194B 4.62
IMV INC (IMV) Canada $0.188B 0.00
Nature's Sunshine Products (NATR) United States $0.182B 24.00
Taiwan Liposome (TLC) Taiwan $0.182B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.182B 0.00
Aquestive Therapeutics (AQST) United States $0.171B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.137B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.135B 0.00
PharmAthene (ALT) United States $0.126B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.126B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.117B 0.00
Recro Pharma (REPH) United States $0.114B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.108B 0.00
Sundial Growers (SNDL) Canada $0.092B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.091B 0.00
CV Sciences (CVSI) United States $0.088B 0.00
Heat Biologics (HTBX) United States $0.082B 0.00
Otonomy (OTIC) United States $0.079B 0.00
SCYNEXIS (SCYX) United States $0.078B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.076B 0.00
CTI BioPharma (CTIC) United States $0.074B 0.00
Hemispherx BioPharma (AIM) United States $0.068B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.067B 0.00
Onconova Therapeutics (ONTX) United States $0.066B 0.00
Biomerica (BMRA) United States $0.065B 0.00
Nivalis Therapeutics (ALPN) United States $0.065B 0.00
Iterum Therapeutics (ITRM) Ireland $0.058B 0.00
Aclaris Therapeutics (ACRS) United States $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.056B 0.00
MediWound (MDWD) Israel $0.054B 0.00
Infinity Pharmaceuticals (INFI) United States $0.054B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 29.73
GTx (ONCT) United States $0.049B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.049B 103.82
IsoRay (ISR) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.047B 0.00
Lipocine (LPCN) United States $0.045B 0.00
PolarityTE (PTE) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Addex Therapeutics (ADXN) Switzerland $0.040B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.038B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.037B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
Mannatechorporated (MTEX) United States $0.034B 6.48
ElectroCore (ECOR) United States $0.034B 0.00
AgeX Therapeutics (AGE) United States $0.028B 0.00
Cardiome Pharma (CORV) Canada $0.028B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.026B 0.00
Jaguar Animal Health (JAGX) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
Bio-Path Holdings (BPTH) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Novan (NOVN) United States $0.019B 0.00
Can-Fite Biopharma (CANF) Israel $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.012B 0.00
Shineco (TYHT) China $0.011B 0.00
Vical (BBI) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
HANCOCK JAFFE (HJLI) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00